Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1569 ARTÍCULOS , VIENDO DEL 166 AL 180

Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorder

Lozupone M, La Montagna M, D'Urso F, Piccininni C, Sardone R, Dibello V, Giannelli G, Solfrizzi V, Greco A, Daniele A, Quaranta N, Seripa D, Bellomo A, Logroscino G, Panza F.

Expert Opin Pharmacother. 2018 Jun;19(8):823-842. doi: 10.1080/14656566.2018.1471136. Epub 2018 May 4.

The Dynamics of Neurosteroids and Sex-Related Hormones in the Pathogenesis of Alzheimer's Disease

Hasanpour M, Nourazarian A, Geranmayeh MH, Nikanfar M, Khaki-Khatibi F, Rahbarghazi R.

Neuromolecular Med. 2018 Jun;20(2):215-224. doi: 10.1007/s12017-018-8493-y. Epub 2018 May 4.

CD200-, CX3CL1-, and TREM2-mediated neuron-microglia interactions and their involvements in Alzheimer's disease

Zhang L, Xu J, Gao J, Wu Y, Yin M, Zhao W.

Rev Neurosci. 2018 Nov 27;29(8):837-848. doi: 10.1515/revneuro-2017-0084.

Myelin injury in the central nervous system and Alzheimer's disease

Wang SS, Zhang Z, Zhu TB, Chu SF, He WB, Chen NH.

Brain Res Bull. 2018 Jun;140:162-168. doi: 10.1016/j.brainresbull.2018.05.003. Epub 2018 May 3.

Blood Ammonia as a Possible Etiological Agent for Alzheimer's Disease

Jin YY, Singh P, Chung HJ, Hong ST.

Nutrients. 2018 May 4;10(5):564. doi: 10.3390/nu10050564.

Oldest Old Patients Should be Recruited More in Clinical Trials of Dementia

Park YH.

J Korean Med Sci. 2018 Apr 25;33(19):e146. doi: 10.3346/jkms.2018.33.e146. eCollection 2018 May 7.

OxLDL plasma levels in patients with Alzheimer's disease

Grossi MF, Carvalho MDG, Silveira JN, Gonçalves GS, Gomes KB, Bicalho MA, Silva IFO.

Arq Neuropsiquiatr. 2018 Apr;76(4):241-246. doi: 10.1590/0004-282x20180012.

Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls

Denk J, Oberhauser F, Kornhuber J, Wiltfang J, Fassbender K, Schroeter ML, Volk AE, Diehl-Schmid J, Prudlo J, Danek A, Landwehrmeyer B, Lauer M, Otto M, Jahn H; FTLDc study group.

PLoS One. 2018 May 10;13(5):e0197329. doi: 10.1371/journal.pone.0197329. eCollection 2018.

Ganglioside-Mediated Assembly of Amyloid β-Protein: Roles in Alzheimer's Disease

Matsuzaki K, Kato K, Yanagisawa K.

Prog Mol Biol Transl Sci. 2018;156:413-434. doi: 10.1016/bs.pmbts.2017.10.005. Epub 2018 Feb 1.

From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease

Zetterberg H, Blennow K.

J Alzheimers Dis. 2018;64(s1):S271-S279. doi: 10.3233/JAD-179926.

[Senile Dementia of the Neurofibrillary Tangle Type (SD-NFT)]

Yamada M.

Brain Nerve. 2018 May;70(5):533-541. doi: 10.11477/mf.1416201035.

The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer's disease

Salminen A, Kaarniranta K, Kauppinen A.

Cell Mol Life Sci. 2018 Sep;75(17):3099-3120. doi: 10.1007/s00018-018-2844-6. Epub 2018 May 19.

Role of Blood-Brain Barrier in Alzheimer's Disease

Cai Z, Qiao PF, Wan CQ, Cai M, Zhou NK, Li Q.

J Alzheimers Dis. 2018;63(4):1223-1234. doi: 10.3233/JAD-180098.

Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones?

Hölscher C, De Felice FG, Greig NH, Ferreira ST.

Neuropharmacology. 2018 Jul 1;136(Pt B):159. doi: 10.1016/j.neuropharm.2018.05.021. Epub 2018 May 18.

O-GlcNAcylation and neuronal energy status: Implications for Alzheimer's disease

Pinho TS, Verde DM, Correia SC, Cardoso SM, Moreira PI.

Ageing Res Rev. 2018 Sep;46:32-41. doi: 10.1016/j.arr.2018.05.003. Epub 2018 May 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias